WELLS FARGO & COMPANY/MN - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 174 filers reported holding ACORDA THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 1.91 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$24,000
-64.7%
34,689
-74.0%
0.00%
Q3 2020$68,000
-16.0%
133,194
+22.3%
0.00%
Q2 2020$81,000
-28.3%
108,898
-10.0%
0.00%
Q1 2020$113,000
-45.4%
121,054
+18.9%
0.00%
Q4 2019$207,000
-30.3%
101,825
-1.7%
0.00%
Q3 2019$297,000
-52.9%
103,581
+25.9%
0.00%
Q2 2019$631,000
-49.6%
82,300
-12.7%
0.00%
Q1 2019$1,253,000
+3.5%
94,235
+21.2%
0.00%
Q4 2018$1,211,000
-13.7%
77,760
+8.9%
0.00%
Q3 2018$1,403,000
-33.3%
71,402
-2.5%
0.00%
-100.0%
Q2 2018$2,102,000
-16.1%
73,243
-39.0%
0.00%0.0%
Q1 2018$2,506,000
+22.2%
120,081
+25.6%
0.00%0.0%
Q4 2017$2,051,000
+0.0%
95,637
-19.6%
0.00%0.0%
Q3 2017$2,050,000
+23.0%
118,957
+40.6%
0.00%0.0%
Q2 2017$1,667,000
+57.3%
84,583
+67.5%
0.00%
Q1 2017$1,060,000
+4.3%
50,499
-6.5%
0.00%
Q4 2016$1,016,000
-21.2%
54,031
-12.5%
0.00%
Q3 2016$1,290,000
-24.7%
61,733
-8.0%
0.00%
-100.0%
Q2 2016$1,713,000
-10.7%
67,134
-7.6%
0.00%0.0%
Q1 2016$1,919,000
-36.3%
72,618
+3.2%
0.00%0.0%
Q4 2015$3,011,000
+60.2%
70,390
-0.7%
0.00%0.0%
Q3 2015$1,880,000
-25.6%
70,906
-6.5%
0.00%0.0%
Q2 2015$2,527,000
-59.3%
75,797
-59.4%
0.00%0.0%
Q1 2015$6,210,000
+57.3%
186,578
+93.1%
0.00%
-50.0%
Q4 2014$3,949,000
+15.8%
96,620
-4.0%
0.00%
+100.0%
Q3 2014$3,410,000
+5.3%
100,672
+4.8%
0.00%0.0%
Q2 2014$3,239,000
-22.9%
96,093
-13.2%
0.00%
-50.0%
Q1 2014$4,200,000
-1.5%
110,768
-24.1%
0.00%0.0%
Q4 2013$4,264,000
-37.2%
146,034
-26.4%
0.00%
-33.3%
Q3 2013$6,787,000
+25.5%
198,450
+21.0%
0.00%0.0%
Q2 2013$5,410,000163,9980.00%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 428,000$8,046,0001.90%
SCOPIA CAPITAL MANAGEMENT LP 4,532,067$85,203,0001.61%
DLD Asset Management, LP 247,300$4,656,0001.52%
Broadfin Capital, LLC 644,153$12,110,0001.34%
Perceptive Advisors 720,000$13,536,0000.96%
DLD Asset Management, LP 135,493$2,547,0000.83%
Malaga Cove Capital, LLC 51,013$971,0000.64%
Baker Brothers Advisors 3,301,791$62,074,0000.61%
Worth Venture Partners, LLC 29,300$551,0000.59%
Spark Investment Management LLC 327,900$6,164,0000.51%
View complete list of ACORDA THERAPEUTICS INC shareholders